IPO registrations (S-1, F-1) · Registrants
Humacyte, Inc.
- SEC CIK
- 1818382 · filings on EDGAR ↗
- Former names
- Alpha Healthcare Acquisition Corp. (2020–2021)
- Registration
- Form S-1, first filed 2020-08-04, last 2021-10-22; 2 initial registrations, 3 amendments
- Outcome
- Final prospectus filed 2020-09-18; declared effective 2020-09-17
- Industry (SIC)
- Biological Products, (No Diagnostic Substances) 2836
- Incorporated in
- DE
- Business address
- 2525 EAST NORTH CAROLINA HIGHWAY 54, Durham, NC 27713
- EIN
- 85-1763759
- Ticker
- HUMA (Nasdaq)
- EDGAR entity type
- operating
- Insiders and CEO pay
- Humacyte, Inc. on the corporate pages
Offering terms
- Final price
- $10.00 per share (424B4 filed 2020-09-18, an initial public offering)
- Shares sold
- 10,000,000
- Gross proceeds
- $100,000,000 before underwriting discounts and any over-allotment option
- Listing
- Nasdaq under the symbol AHAC
- Lead underwriters
- Oppenheimer
- Syndicate
- Northland Securities
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Business registration: HUMACYTE INC. Fuzzy (name and state)
- Lobbying client: HUMACYTE Fuzzy (name and state)
- Lobbying client: HUMACYTE Fuzzy (name and state)
- Lobbying client: HUMACYTE Fuzzy (name and state)
- Lobbying client: HUMACYTE, INC. Fuzzy (name and state)
- Lobbying client: HUMACYTE, INC. Fuzzy (name and state)
- Lobbying client: HUMACYTE, INC. Fuzzy (name and state)
- Lobbying client: HUMACYTE INCORPORATED Fuzzy (name and state)
- SEC filer: Alpha Healthcare Acquisition Corp. EXACT (CIK (EXACT))
- Person page: Susan Richards Windham-Bannister Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director))
Filings 15
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2020-08-04 | S-1 | S-1 (registration) | Alpha Healthcare Acquisition Corp. | 0001213900-20-020196 ↗ |
| 2020-09-01 | S-1/A | S-1/A (amendment) | Alpha Healthcare Acquisition Corp. | 0001213900-20-024845 ↗ |
| 2020-09-14 | S-1/A | S-1/A (amendment) | Alpha Healthcare Acquisition Corp. | 0001213900-20-026470 ↗ |
| 2020-09-17 | EFFECT | EFFECT (declared effective) | Alpha Healthcare Acquisition Corp. | 9999999995-20-002478 ↗ |
| 2020-09-18 | 424B4 | 424B4 (final prospectus) | Alpha Healthcare Acquisition Corp. | 0001213900-20-027364 ↗ |
| 2021-08-04 | EFFECT | EFFECT (declared effective) | Alpha Healthcare Acquisition Corp. | 9999999995-21-003041 ↗ |
| 2021-09-17 | S-1 | S-1 (registration) | Humacyte, Inc. | 0001104659-21-116962 ↗ |
| 2021-10-22 | S-1/A | S-1/A (amendment) | Humacyte, Inc. | 0001104659-21-128615 ↗ |
| 2021-10-25 | EFFECT | EFFECT (declared effective) | Humacyte, Inc. | 9999999995-21-004018 ↗ |
| 2021-11-24 | EFFECT | EFFECT (declared effective) | Humacyte, Inc. | 9999999995-21-004480 ↗ |
| 2022-03-31 | EFFECT | EFFECT (declared effective) | Humacyte, Inc. | 9999999995-22-000786 ↗ |
| 2022-09-09 | EFFECT | EFFECT (declared effective) | Humacyte, Inc. | 9999999995-22-002653 ↗ |
| 2022-09-09 | EFFECT | EFFECT (declared effective) | Humacyte, Inc. | 9999999995-22-002654 ↗ |
| 2022-09-14 | EFFECT | EFFECT (declared effective) | Humacyte, Inc. | 9999999995-22-002693 ↗ |
| 2023-06-21 | EFFECT | EFFECT (declared effective) | Humacyte, Inc. | 9999999995-23-001808 ↗ |
Prospectus pages read 2
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2020-09-14 | S-1/A | registration statement | $10.00 | 10,000,000 | $100,000,000 | Nasdaq AHAC | 2 | primary document; price sentence, shares headline, proceeds table, cover names 2 | document ↗ | |
| 2020-09-18 | 424B4 | final prospectus | $10.00 | 10,000,000 | $100,000,000 | Nasdaq AHAC | 2 | primary document; price sentence, shares headline, proceeds table, cover names 2 | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| AHAC Sponsor LLC | TenPercentOwner | 2 | 2020 | ||
| CARLSON TERRANCE L | Director | 1 | 2020 | ||
| Robertson Brian Clanton | Director | 1 | 2020 | ||
| Shukla Rajiv | Director; Director,Officer,TenPercentOwner | Chief Executive Officer | 5 | 2020–2023 | |
| Springer Bruce A | Director | 1 | 2020 | ||
| Sturgeon Patrick A | Officer | CFO | 1 | 2020 | |
| Xie Yili Kevin | Director | 1 | 2020 | ||
| Ayabudge LLC | TenPercentOwner | 9 | 2021–2023 | ||
| Binder Gordon M | Director | 7 | 2021–2024 | ||
| Brown Emery N. | Director | 7 | 2021–2026 | ||
| Constantino Michael T. | Director | 14 | 2021–2026 | ||
| DeAngelis Kiernan Thomas | Officer | Chief Medical Officer | 2 | 2021 | |
| Dougan Brady W | Director; Director,TenPercentOwner | 37 | 2021–2026 | ||
| Lawson Jeffrey Harold | Director,Officer | Chief Surgical Officer | 2 | 2021 | |
| Niklason Laura E | Director,Officer; Director,Officer,TenPercentOwner | President, CEO and Director | 37 | 2021–2026 | |
| Pope Todd | Director | 6 | 2021–2025 | ||
| Prichard Heather Ledbetter | Officer | Chief Operating Officer | 9 | 2021–2025 | |
| Sander Dale A. | Officer | CFO and Chief Corp. Deve. Off.; CFO and Chief Corp. Dev. Off; CFO & CCDO | 12 | 2021–2026 | |
| Scheessele William John | Officer | Chief Commercial Officer | 8 | 2021–2025 | |
| Sebelius Kathleen | Director | 11 | 2021–2026 | ||
| Tente William Edward | Officer | Chief Regulatory Officer | 2 | 2021 | |
| Wallace Max N. | Director | 10 | 2021–2026 | ||
| Windham-Bannister Susan Richards | Director | 7 | 2021–2026 | person page Fuzzy | |
| FRESENIUS MEDICAL CARE HOLDINGS INC /NY/ | Other; TenPercentOwner | 2 | 2021–2025 | ||
| Parikh Shamik J | Officer | Chief Medical Officer | 8 | 2022–2026 | |
| Seimetz Diane | Director | 6 | 2022–2026 | ||
| Green Charles Bruce | Director | 10 | 2022–2026 | ||
| Cao Yang | Officer | Chief Regulatory Officer | 4 | 2022–2025 | |
| Bamforth John Philip | Director | 4 | 2024–2026 | ||
| Jones Keith Anthony | Director | 7 | 2024–2026 | ||
| COWARD D SCOTT | Director | 1 | 2026 | ||
| Kuznik Paul Brian | Director | 1 | 2026 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Business registration | HUMACYTE INC. | NC | State business registries | name and state |
| Form D issuer | Humacyte, Inc. | NC | Form D private offerings | name and state |
| Lobbying client | HUMACYTE | NC | Federal lobbying (LDA) | name and state |
| Lobbying client | HUMACYTE | NC | Federal lobbying (LDA) | name and state |
| Lobbying client | HUMACYTE | NC | Federal lobbying (LDA) | name and state |
| Lobbying client | HUMACYTE, INC. | NC | Federal lobbying (LDA) | name and state |
| Lobbying client | HUMACYTE, INC. | NC | Federal lobbying (LDA) | name and state |
| Lobbying client | HUMACYTE, INC. | NC | Federal lobbying (LDA) | name and state |
| Lobbying client | HUMACYTE INCORPORATED | NC | Federal lobbying (LDA) | name and state |
| Patent assignee | Humacyte, Inc | NC | Patents (USPTO) | name and state |
| SEC filer | Humacyte, Inc. | SEC filers (EDGAR) | CIK (EXACT) | |
| Trademark owner | Humacyte, Inc. | NC | Trademarks (USPTO) | name and state |
| Person page | Susan Richards Windham-Bannister | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Biological Products, (No Diagnostic Substances), NC first:
- ALDAGEN INC NC
- FENNEC PHARMACEUTICALS INC. NC
- TENGION INC NC
- Chelsea Therapeutics International, Ltd. NC
- AERIE PHARMACEUTICALS INC NC
- PRECISION BIOSCIENCES INC NC
- Axium Pharmaceuticals Inc. NC
- Immunovant, Inc. NC
- PROKIDNEY CORP. NC
- Pelthos Therapeutics Inc. NC
In other datasets, the same topic (Health) in NC:
- Nonprofit: 24 FOUNDATION INC (Nonprofits (IRS Form 990))
Interests: Biological Products, (No Diagnostic Substances) · Health